These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 30991833)
1. Losartan protects against myocardial ischemia and reperfusion injury Li Y; Yao Y; Li J; Chen Q; Zhang L; Wang QK FASEB J; 2019 Jul; 33(7):8555-8564. PubMed ID: 30991833 [TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade. Lee SW; Won JY; Lee HY; Lee HJ; Youn SW; Lee JY; Cho CH; Cho HJ; Oh S; Chae IH; Kim HS Mol Med; 2011; 17(9-10):1095-106. PubMed ID: 21738954 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway. Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831 [TBL] [Abstract][Full Text] [Related]
4. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1. Zhang J; Huang J; Qi T; Huang Y; Lu Y; Zhan T; Gong H; Zhu Z; Shi Y; Zhou J; Yu L; Zhang X; Cheng H; Ke Y FASEB J; 2019 Jan; 33(1):1124-1137. PubMed ID: 30102570 [TBL] [Abstract][Full Text] [Related]
6. Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Galaup A; Gomez E; Souktani R; Durand M; Cazes A; Monnot C; Teillon J; Le Jan S; Bouleti C; Briois G; Philippe J; Pons S; Martin V; Assaly R; Bonnin P; Ratajczak P; Janin A; Thurston G; Valenzuela DM; Murphy AJ; Yancopoulos GD; Tissier R; Berdeaux A; Ghaleh B; Germain S Circulation; 2012 Jan; 125(1):140-9. PubMed ID: 22086875 [TBL] [Abstract][Full Text] [Related]
7. Endothelium-Derived 5-Methoxytryptophan Protects Endothelial Barrier Function by Blocking p38 MAPK Activation. Chu LY; Wang YF; Cheng HH; Kuo CC; Wu KK PLoS One; 2016; 11(3):e0152166. PubMed ID: 27002329 [TBL] [Abstract][Full Text] [Related]
8. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions. Li R; Ren M; Chen N; Luo M; Zhang Z; Wu J PLoS One; 2012; 7(5):e37195. PubMed ID: 22606350 [TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation. Lee CS; Kim YG; Cho HJ; Park J; Jeong H; Lee SE; Lee SP; Kang HJ; Kim HS Sci Rep; 2016 Jul; 6():29393. PubMed ID: 27381080 [TBL] [Abstract][Full Text] [Related]
11. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825 [TBL] [Abstract][Full Text] [Related]
12. Puerarin Protects Against LPS-Induced Vascular Endothelial Cell Hyperpermeability via Preventing Downregulation of Endothelial Cadherin. Deng HF; Wang S; Wang XL; Li L; Xie F; Zeng ZW; Zhang WX Inflammation; 2019 Aug; 42(4):1504-1510. PubMed ID: 31102123 [TBL] [Abstract][Full Text] [Related]
13. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin. Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L Elife; 2021 Apr; 10():. PubMed ID: 33908348 [TBL] [Abstract][Full Text] [Related]
14. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin. Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L Elife; 2020 Apr; 9():. PubMed ID: 32312382 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis. Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier. Kim SR; Suh W Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882 [TBL] [Abstract][Full Text] [Related]
17. Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin Internalization. Lei X; Chen M; Huang M; Li X; Shi C; Zhang D; Luo L; Zhang Y; Ma N; Chen H; Liang H; Ye W; Zhang D Theranostics; 2018; 8(2):384-398. PubMed ID: 29290815 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Lin MT; Yen ML; Lin CY; Kuo ML Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]